Structural classification of CDR-H3 revisited: a lesson in antibody modeling
Related Experiment Video
Updated: Jul 5, 2026

Single Particle Cryo-Electron Microscopy: From Sample to Structure
Published on: May 29, 2021
Daisuke Kuroda1, Hiroki Shirai, Masato Kobori
1Institute for Protein Research, Osaka University, Suita, Osaka, Japan. dkuroda@protein.osaka-u.ac.jp
Insights
We revised H3-rules for classifying antibody heavy chain third complementarity-determining region (CDR-H3) structures. This improved modeling scheme aids antibody drug discovery and evaluation by analyzing CDR-H3 features.
Area of Science:
- Immunology
- Structural Biology
- Biochemistry
Background:
- The third complementarity-determining region of the heavy chain (CDR-H3) is crucial for antigen recognition due to its central position in the antibody's antigen-binding site.
- CDR-H3 exhibits substantial variability in length, sequence, and structure, making its accurate modeling a critical challenge in antibody structure prediction.
- Previous 'H3-rules' provided a classification for CDR-H3 structures based on amino acid sequences.
Purpose of the Study:
- To revise and improve the existing H3-rules for more accurate CDR-H3 structure modeling.
- To identify common structural features of CDR-H3 in therapeutic antibodies.
- To discuss the concept of antibody druggability as an evaluation metric in antibody drug discovery.
Main Methods:
- Analysis of an increased number of experimentally determined antibody structures.
- Revision of the original H3-rules classification scheme.
- Identification of conserved structural motifs and properties within CDR-H3 of antibody drugs.
Main Results:
- An updated and refined classification scheme for CDR-H3 structures.
- Characterization of common structural features specific to CDR-H3 in antibody drugs.
- Demonstration of the utility of antibody druggability as an evaluation indicator.
Conclusions:
- The revised H3-rules offer an improved method for modeling CDR-H3 structures.
- Understanding CDR-H3 features is vital for antibody design and drug development.
- The concept of antibody druggability provides a valuable framework for assessing antibody candidates.
Abstract:
Among the six complementarity-determining regions (CDRs) in the variable domains of an antibody, the third CDR of the heavy chain (CDR-H3), which lies in the center of the antigen-binding site, plays a particularly important role in antigen recognition. CDR-H3 shows significant variability in its length, sequence, and structure. Although difficult, model building of this segment is the most critical step in antibody modeling. Since our first proposal of the "H3-rules," which classify CDR-H3 structure based on amino acid sequence, the number of experimentally determined antibody structures has increased. Here, we revise these H3-rules and propose an improved classification scheme for CDR-H3 structure modeling. In addition, we determine the common features of CDR-H3 in antibody drugs as well as discuss the concept of "antibody druggability," which can be applied as an indicator of antibody evaluation during drug discovery.
Related Concept Videos
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Prochirality
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Molecular Models
